300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Haiti
Kyrgyzstan
Guinea
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Morocco
Venezuela
Myanmar
Uganda
Uruguay
Turkey
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Europe
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Qatar
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Angola
Bahamas
Bolivia
Cyprus
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Semyon Dukach, Founding Partner at One Way Ventures

Semyon Dukach

Founding Partner @ One Way Ventures

Boston, United States

Semyon Dukach is a seed investor at One Way Ventures in Boston focused on Software and SaaS. Semyon Dukach is the Founding Partner of One Way Ventures. He previously worked at SharpSpring as a Board Chairman. Semyon Dukach attended Massachusetts Institute of Technology.

Total investments:
54
Last investment:
Lead investor:
30%

Last updated:

Industries Semyon Dukach invests in

SoftwareSaaSEducationHealth CareMobile

Stages Semyon Dukach invests in

SeedAngelPre-SeedFunding RoundConvertible Note

Countries Semyon Dukach invests in

United StatesUkraineCanadaUnited Kingdom

Round sizes

Seed $45k–$4.5MAngel $278k–$705kPre-Seed $100k–$118k

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$45k–$4.5M
Angel
$278k–$705k
Pre-Seed
$100k–$118k

Investment Focus

Industry

  • Software 11 (20%)
  • SaaS 9 (17%)
  • Education 7 (13%)
  • Health Care 7 (13%)
  • Mobile 5 (9%)
See all 129 industries →

Stage

  • Seed 29 (54%)
  • Angel 8 (15%)
  • Pre-Seed 3 (6%)
  • Funding Round 3 (6%)
  • Convertible Note 3 (6%)
See all 7 stages →

Country

  • United States 41 (76%)
  • Ukraine 2 (4%)
  • Canada 1 (2%)
  • United Kingdom 1 (2%)

Investments

CompanyDescriptionRoundLinks
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source. $7.7M / Seed / Mar 23, 2026
Provision is automating construction with AI. $7M / Seed / Oct 15, 2025
Machinery Partner helps buyers and sellers of heavy equipment to grow faster and easier with the technology and industry expertise to match their needs. $8M / Series A / Dec 05, 2023
Onyx Private is a modern and more accessible private bank for the new generation of young professionals, investors, and entrepreneurs. We offer a premium and digital banking experience with a white-glove concierge service for all your personal finance, wealth and lifestyle needs. $4.1M / Seed / May 22, 2023
Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application programming interface for handling purchases, logistics, and configuration, allowing hospitals and healthcareorganizations to manage their digital health remote patient monitoring devices and supplies. $4.5M / Seed / Feb 08, 2023
Onyx Private is a modern and more accessible private bank for the new generation of young professionals, investors, and entrepreneurs. We offer a premium and digital banking experience with a white-glove concierge service for all your personal finance, wealth and lifestyle needs. $500K / Seed / May 02, 2022
Machinery Partner helps buyers and sellers of heavy equipment to grow faster and easier with the technology and industry expertise to match their needs. $4.5M / Seed / Aug 12, 2021
Influ2 is the first person-based marketing platform, pioneering a new approach to account-based marketing. The solution empowers B2B marketers to target chosen decision-makers, capture their intent, and track engagement at the individual level. The company has 75+ enterprise and medium-sized clients globally, including Fortune 500 B2B enterprisessuch as NVIDIA, Capgemini, and Episerver. Influ2 runs offices in NY and CA, with 50+ employees on board. With Influ2, every user’s engagement is identified. Having this information helps B2B marketers develop more thoughtful and engaging campaigns that result in a 4-7x increase in leads. Influ2 platform allows users to build an audience, upload personalized messages & visuals, and monitor all the interactions on both account and individual levels The behavioral scoring model identifies leads before they submit a lead form. Influ2 includes a person tracker, so marketers can see everyone who has interacted with their campaign by name, company, and other related data. The solution is compatible with Salesforce, HubSpot, Marketo, Creatio, Outreach, ActiveCampaign, and many other CRM and marketing automation platforms. $3.4M / Seed / Sep 24, 2020
Humanity is a healthcare company that aims to extend the healthspan of humanity. It develops a software application designed to provide information on how to stop the aging process. The company's service allows people to try different interventions and solutions to help move those biomarkers in a positive direction and thus reduce, and in somecases, stop the loss of function and thus the aging damage.Founded in 2019 by Peter Ward and Michael Geer, Humanity is headquartered in Boston, Massachusetts. $2.5M / Seed / Aug 20, 2020
BRIO Systems offers a complete COVID-19 testing system to help employers keep teams safe and businesses on track.The turnkey solution for COVID-19 screening that urgently addresses the needs of employers and providers of critical/essential infrastructure. It bundles laboratory testing, dropship fulfillment of collection kits, testrequisitioning, medical supervision, and digital reporting in a single product, working with a network of FDA-certified laboratories to support up to 50, 000 tests daily. BRIO is working with leading companies across a variety of verticals, helping them protect their workforce and make data-driven risk-mitigation decisions.In 2017, Boris Lipchin and Thos Niles established the company in Boston, Massachusetts. $1.9M / Seed / Aug 05, 2020
See all 54 investments →

Co-Investors

One Way Ventures

About One Way Ventures

VC Fund · Boston, United States

One Way Ventures is a seed-stage fund that invests in immigrant tech founders.

One Way Ventures Contacts

NameEmailPhoneSocials
Semyon Dukach
Semyon Dukach Founding Partner
Alissa Carroll
Alissa Carroll Investment Analyst
Eugene Malobrodsky
Eugene Malobrodsky General Partner
Joe Zhou
Joe Zhou Limited Partner
Lex Zhao
Lex Zhao Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 7 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Haiti
Kyrgyzstan
Guinea
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Morocco
Venezuela
Myanmar
Uganda
Uruguay
Turkey
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Europe
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Qatar
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Angola
Bahamas
Bolivia
Cyprus
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Semyon Dukach invest in?

Semyon Dukach invests primarily in Software, SaaS and Education startups, most often at Seed and Angel stage. Most of the 54 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Semyon Dukach's check size?

Semyon Dukach typically joins rounds of $45k–$4.5M at Seed, $278k–$705k at Angel and $100k–$118k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Semyon Dukach participates in.

How do I contact Semyon Dukach?

Public channels for Semyon Dukach include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Semyon Dukach last invest?

The most recent investment recorded for Semyon Dukach closed in Mar 2026. Shizune tracks 54 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Semyon Dukach Semyon Dukach Find email